| Application no. and date | 00988416.4 (espacenet) (Federated) (European Patent Register), 20001229 | | Patent/reg. no. and date | DK/EP 1246639, 20070214 | | Publication date | 20021009 | | Priority no. and date | GB 9930882, 19991230 | | EP pub. no. and date |
EP 1246639 20021009 | | Effective date | | | Applicant/owner | NPS Pharmaceuticals, Inc., 550 Hills Drive, 3rd Floor
Bedminster NJ 07921, US | | Applicant ref. no. | P32461DK01 | | Inventor | ISAACS, Indu, J., 31 Andover Country Club Lane
Andover, MA 01810, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 47/02 (2006.01) , A61K 47/18 (2006.01) , A61K 47/26 (2006.01) | | Title | GLP-2-formuleringer | | Int. application no. | US2000035512 | | Int. publication no. | WO2001049314 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
